TuisEXK • FRA
add
Exact Sciences Corp
Vorige sluiting
€87,20
Dagwisseling
€86,88 - €86,88
Jaarwisseling
€33,80 - €88,16
Markkapitalisasie
19,71 mjd USD
Gemiddelde volume
1,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 878,38 m | 23,12% |
Bedryfskoste | 697,33 m | 30,50% |
Netto inkomste | -85,96 m | 90,06% |
Netto winsgrens | -9,79 | 91,92% |
Wins per aandeel | -0,21 | -250,00% |
EBITDA | -25,15 m | -321,14% |
Effektiewe belastingkoers | -1,02% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 964,71 m | -7,06% |
Totale bates | 5,86 mjd | -1,14% |
Totale aanspreeklikheid | 3,46 mjd | -1,88% |
Totale ekwiteit | 2,40 mjd | — |
Uitstaande aandele | 190,89 m | — |
Prys om te bespreek | 6,93 | — |
Opbrengs op bates | -3,46% | — |
Opbrengs op kapitaal | -4,09% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -85,96 m | 90,06% |
Kontant van bedrywe | 151,69 m | 222,31% |
Kontant van beleggings | 91,12 m | 317,61% |
Kontant van finansiering | -75,87 m | -822,67% |
Netto kontantverandering | 166,96 m | 1 294,93% |
Beskikbare kontantvloei | 74,97 m | 260,39% |
Meer oor
Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer.
In November 2025, Abbott Laboratories agreed to acquire Exact Sciences in a deal worth roughly $21 billion. Wikipedia
HUB
Gestig
01 Jan. 1995
Hoofkwartier
Webwerf
Werknemers
7 150
